Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$109.01 USD
+0.17 (0.16%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $108.91 -0.10 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/31/2024
Time: AMC |
6/2024 | $4.71 | -1.34% |
Earnings Summary
For their last quarter, Jazz Pharmaceuticals (JAZZ) reported earnings of $2.68 per share, missing the Zacks Consensus Estimate of $4.14 per share. This reflects a negative earnings surprise of 35.27%. Look out for JAZZ's next earnings release on July 31, 2024. For the next earning release, we expect the company to report earnings of $4.71 per share, reflecting a year-over-year increase of 4.43%.
Earnings History
Price & Consensus
Zacks News for JAZZ
Is The Options Market Predicting A Spike In JAZZ Pharmaceuticals (JAZZ) Stock?
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services